Latest News in the pharma Industry

All

Recipharm opens new GMP suite for clinical trial material

Recipharm opens new GMP suite for clinical trial material

24 Apr 2017

The $750k investment is intended to produce CTM for clinical studies up to Phase II for non-sterile dosage forms, including metered dose inhalers and semi-solid topical products.

Read more 
Lilly's breast cancer study of abemaciclib demonstrated superior progression-free survival at interim analysis

Lilly's breast cancer study of abemaciclib demonstrated superior progression-free survival at interim analysis

24 Apr 2017

The Phase III study compared abemaciclib in combination with an aromatase inhibitor versus an aromatase inhibitor alone in patients with HR+, HER2- advanced breast cancer.

Read more 
Recipharm delivers first serialised batch to Saudi Arabia

Recipharm delivers first serialised batch to Saudi Arabia

23 Apr 2017

Company has invested €300,000 into the project, which is part of a wider €40 million investment into new serialisation technology and processes to comply with the European Falsified Medicines Directive.

Read more 
Sandoz proposed biosimilars rituximab and etanercept recommended for approval in Europe

Sandoz proposed biosimilars rituximab and etanercept recommended for approval in Europe

23 Apr 2017

Company receives positive CHMP opinions for biosimilars rituximab and etanercept to treat immunological diseases. Biosimilar rituximab also recommended to treat blood cancers.

Read more 
BMS-986036 shows consistent improvement in liver fat, liver injury and fibrosis in patients with NASH in Phase II trial

BMS-986036 shows consistent improvement in liver fat, liver injury and fibrosis in patients with NASH in Phase II trial

23 Apr 2017

Primary endpoint of significant reduction in liver fat achieved following 16 weeks of treatment with BMS-986036.

Read more 
Pfizer unveils ATLAS, an Interactive, website that provides global antibiotic resistance surveillance data across 60 countries

Pfizer unveils ATLAS, an Interactive, website that provides global antibiotic resistance surveillance data across 60 countries

23 Apr 2017

Website can help inform global health strategies to mitigate the threat of antimicrobial resistance.

Read more 
CanniMed Therapeutics commences cannabis oils facility expansion

CanniMed Therapeutics commences cannabis oils facility expansion

20 Apr 2017

The GMP-compliant ethanol extraction facility will ensure ample supply of cannabinoid-based raw materials for future product development and innovation.

Read more 
World’s largest society for regulatory professionals increases investment in Europe

World’s largest society for regulatory professionals increases investment in Europe

20 Apr 2017

An investment of more than 2 million euro over 3 years is planned to launch new events and resources.

Read more 
Lilly to present data for galcanezumab for the prevention of migraine at the AAN annual meeting

Lilly to present data for galcanezumab for the prevention of migraine at the AAN annual meeting

20 Apr 2017

Treatment could help to reduce the number of days lost to migraine.

Read more 
BioInvent expands manufacturing facility with Mobius bioreactors from Merck

BioInvent expands manufacturing facility with Mobius bioreactors from Merck

20 Apr 2017

Fully scalable system streamlines drug development and production.

Read more 
Merck partners with Drugs for Neglected Diseases initiative

Merck partners with Drugs for Neglected Diseases initiative

19 Apr 2017

Merck is opening its compound library to DNDi to help find cures for leishmaniasis and Chagas disease.

Read more 
Nivalis Therapeutics  and Alpine Immune Sciences agree to merge

Nivalis Therapeutics and Alpine Immune Sciences agree to merge

19 Apr 2017

Combined company well capitalized with $90 million in funding to advance discovery and development.

Read more